FDA Notices of Judgment Collection, 1908-1966

Search

Start Over Titles 3921. Misbranding of methamphetamine hydrochloride tablets, pentobarbital sodium capsules, Tricombisul tablets, thyroid tablets, and Amytal Sodium ( capsules. U. S. v. Andrew J. Kennedy (Kennedy Drugs), and Paul J. Argust. Pleas of guilty. Fine of $400 against Defendant Kennedy and $200 against Defendant Argust. ✖Remove constraint Titles: 3921. Misbranding of methamphetamine hydrochloride tablets, pentobarbital sodium capsules, Tricombisul tablets, thyroid tablets, and Amytal Sodium ( capsules. U. S. v. Andrew J. Kennedy (Kennedy Drugs), and Paul J. Argust. Pleas of guilty. Fine of $400 against Defendant Kennedy and $200 against Defendant Argust. Defendants Andrew J. Kennedy, trading as Kennedy Drugs, Los Angeles, Calif., and Paul J. Argust, a pharmacist employed by Mr. Kennedy. ✖Remove constraint Defendants: Andrew J. Kennedy, trading as Kennedy Drugs, Los Angeles, Calif., and Paul J. Argust, a pharmacist employed by Mr. Kennedy. Issue Dates August 1953 ✖Remove constraint Issue Dates: August 1953 Adjudicating Courts Southern District of California ✖Remove constraint Adjudicating Courts: Southern District of California

Refine by:

  • 3921. Misbranding of methamphetamine hydrochloride tablets, pentobarbital sodium capsules, Tricombisul tablets, thyroid tablets, and Amytal Sodium ( capsules. U. S. v. Andrew J. Kennedy (Kennedy Drugs), and Paul J. Argust. Pleas of guilty. Fine of $400 against Defendant Kennedy and $200 against Defendant Argust.1

  • Andrew J. Kennedy, trading as Kennedy Drugs, Los Angeles, Calif., and Paul J. Argust, a pharmacist employed by Mr. Kennedy.1